Target for cancer therapy: proliferating cells or stem cells.
about
The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progressionCancer stem cells (CSCs), cervical CSCs and targeted therapiesMechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Cancer stem cell targeted therapy: progress amid controversies.Differentiation and transdifferentiation potentials of cancer stem cellsCancer cells mimic in vivo spatial-temporal cell-cycle phase distribution and chemosensitivity in 3-dimensional Gelfoam® histoculture but not 2-dimensional culture as visualized with real-time FUCCI imaging.Mammary gland stem cells and their application in breast cancerEMT, CTCs and CSCs in tumor relapse and drug-resistancePicropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via insulin-like growth factor-1 receptor-independent mechanismPersistence to anti-cancer treatments in the stationary to proliferating transition.Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal.ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma.Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.Spatial-temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsivenessPhotosensitizer-gold nanorod composite for targeted multimodal therapy.Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation.Combining EGFR and mTOR blockade for the treatment of epithelioid sarcomaIonizing radiation induces stemness in cancer cellsSelective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity.TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer.Aptamer-conjugated nanorods for targeted photothermal therapy of prostate cancer stem cells.Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models.Tumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis.Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathwayTraditional Chinese medicine herbal mixture LQ arrests FUCCI-expressing HeLa cells in G₀/G₁ phase in 2D plastic, 2.5D Matrigel, and 3D Gelfoam culture visualized with FUCCI imaging.Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice.Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma.Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice.A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenografts.The evolving concept of cancer and metastasis stem cellsTumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapyTumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse modelsEradication of melanoma in vitro and in vivo via targeting with a Killer-Red-containing telomerase-dependent adenovirus.MicroRNA-21 stimulates epithelial-to-mesenchymal transition and tumorigenesis in clear cell renal cells.Metastasis: recent discoveries and novel treatment strategies.Integration of Golgi trafficking and growth factor signaling by the lipid phosphatase SAC1.
P2860
Q24307439-835767C3-3818-47C1-8509-C6146B243A05Q26747144-5464F949-9C2B-4883-8CE2-77976FAE6101Q26766638-E1BD9C62-C095-43F9-945D-4D77975BF2D4Q26779702-A79A4005-D524-46E3-A507-48A0A99AF86DQ26779931-51357DEE-DE26-4A23-91D4-B8D92A0B071FQ26782242-4630964C-F0FF-481F-9AD1-C470687701E5Q27311397-CA2A3CB8-6DDE-42BC-8DE1-1EB73AB5847AQ28075791-837E477D-915B-4A11-8B62-AD641588AB79Q28082935-E541DC3F-CFED-4501-B1E8-745FD0566708Q30597245-D5997D35-BDC2-4504-ABEE-6C77953B6337Q30834504-C482B831-7391-4183-BA30-CC34C66E46FEQ33590178-B0C29AB1-48ED-4297-A9A1-9902A37D1A2CQ33599165-F517CFF5-E3CD-4834-A316-D96B226752B0Q33624697-990CE04A-9C91-4D53-AF34-441CC7E66ED7Q33829258-6B817895-6F93-442E-98D7-CE16AFD8ADB7Q33952918-CCE57BEC-7B32-4D99-B128-654C76198CB9Q34049873-29CBFE9F-1E49-45BD-8DF6-EB1A30A7B96CQ34104152-B5986C79-B53E-4F05-94C6-24DAA3C73302Q34206363-9E47FD5E-14DB-4D21-998A-8B22C8C7820FQ34395869-2E42EB66-3FA3-4075-A250-80A99CD2E6A6Q34483751-9B2AB238-3B29-464A-830F-1BF0F664DC94Q34619422-00F4A0AF-13A2-4642-A74C-7545C7D87057Q34767644-6C4F02FD-34F6-48A0-B783-42145B9E6E16Q35067893-BCFC0C47-F7E2-40DA-9137-822461B4CA4AQ35550049-C179A3F0-F4DF-43F2-BE6E-DD00AD726B4AQ35740040-441681C6-19EC-4F15-852A-1BA3C9DD42B7Q35741664-5E977C36-F234-46D7-BEFD-BF12A075408DQ35742530-B857B5A7-4F27-4623-9AB6-633211D97555Q35793808-AD974A36-3537-4AC6-8854-ECE46AAF3A67Q35832228-B2BE0274-5E92-4B3B-854A-56744219C67FQ35955227-7A4217FC-F47C-4566-AC5F-7527CE3E7AF5Q35987427-2CB760EB-CC87-4DFD-92A7-3AE98FF19738Q36125108-965EB4A9-3855-4ADC-B70A-6004CA284CF1Q36145729-BB92A8B4-7555-461F-886E-A4E67FEF4620Q36189385-5A2FFF3C-B924-4602-9EFC-1DC5486F36ECQ36198088-A314ADD0-08A7-443D-B493-102317FC3DA3Q36240189-1668388D-84A8-4F7E-9FE6-363D82DCE17CQ36390206-31E309A5-714F-4BAB-8C8A-F4592C1F0316Q36407511-A22F3D7F-91A0-4AA9-A96A-9F2AD4701A5DQ36492075-6958042B-1748-4D3E-B6A2-D12B7543B96B
P2860
Target for cancer therapy: proliferating cells or stem cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Target for cancer therapy: proliferating cells or stem cells.
@ast
Target for cancer therapy: proliferating cells or stem cells.
@en
type
label
Target for cancer therapy: proliferating cells or stem cells.
@ast
Target for cancer therapy: proliferating cells or stem cells.
@en
prefLabel
Target for cancer therapy: proliferating cells or stem cells.
@ast
Target for cancer therapy: proliferating cells or stem cells.
@en
P2860
P356
P1433
P1476
Target for cancer therapy: proliferating cells or stem cells.
@en
P2093
Blagosklonny MV
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404075
P577
2006-03-01T00:00:00Z